We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

PHOspholamban RElated CArdiomyopathy STudy - Intervention (i-PHORECAST)

This study is currently recruiting participants.
Verified October 2016 by M.p. van den Berg, MD, PhD, professor in Cardiology, University Medical Center Groningen
Sponsor:
ClinicalTrials.gov Identifier:
NCT01857856
First Posted: May 20, 2013
Last Update Posted: October 25, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
University Medical Center Groningen
The Interuniversity Cardiology Institute of the Netherlands
ZonMw: The Netherlands Organisation for Health Research and Development
Netherlands: CVON, CardioVascular Research Netherlands
Information provided by (Responsible Party):
M.p. van den Berg, MD, PhD, professor in Cardiology, University Medical Center Groningen
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)